Olmesartan

From Food & Medicine Encyclopedia

(Redirected from Olmesartan Medoxomil)

Olmesartan


Olmesartan is an angiotensin II receptor antagonist used primarily in the treatment of hypertension. It is marketed worldwide by Daiichi Sankyo, a Japanese pharmaceutical company, under the trade name Benicar.

Pharmacology[edit]

Olmesartan works by blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle. This prevents the potent vasoconstrictor effects of angiotensin II, thereby reducing blood pressure.

Clinical Use[edit]

Olmesartan is used to treat high blood pressure in adults and children who are at least 6 years old. It is sometimes given together with other blood pressure medications.

Side Effects[edit]

Common side effects of Olmesartan include dizziness or lightheadedness as your body adjusts to the medication. Serious side effects may include injury or death to the unborn baby if you take the medicine during your second or third trimester.

Interactions[edit]

Olmesartan can interact with other medications, vitamins, or herbs you may be taking. An interaction is when a substance changes the way a drug works. This can be harmful or prevent the drug from working well.

See Also[edit]

References[edit]

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.